The Association of Community Cancer Centers (ACCC), Hematology/Oncology Pharmacy Association (HOPA), National
Community Oncology Dispensing Association, Inc. (NCODA), and Oncology Nursing Society (ONS) have collaborated in gathering
information for and developing this patient education guide. This guide represents a brief summary of the medication derived from
information provided by the drug manufacturer and other resources. This guide does not cover all existing information related to the
possible uses, directions, doses, precautions, warnings, interactions, adverse effects, or risks associated with this medication and should
not substitute for the advice of a qualified healthcare professional. Provision of this guide is for informational purposes only and does
not constitute or imply endorsement, recommendation, or favoring of this medication by ACCC, HOPA, NCODA, or ONS, who assume
no liability for and cannot ensure the accuracy of the information presented. The collaborators are not making any representations with
respect to the medications whatsoever, and any and all decisions, with respect to such medications, are at the sole risk of the individual
consuming the medication. All decisions related to taking this medication should be made with the guidance and under the direction of a
qualified healthcare professional.
Permission:
Oral Chemotherapy Education (OCE) sheets are provided as a free educational resource for patients with cancer in need of
concise, easy-to-understand information about oral cancer drugs. Healthcare providers are permitted to copy and distribute the sheets to
patients as well as direct patients to the OCE website for information. However, commercial reproduction or reuse, as well as rebranding
or reposting of any type, are strictly prohibited without permission of the copyright holder. Please email permission requests and licensing
inquiries to Contact@NCODA.org.
Cookies are required to agree to our terms of service. We only use this cookie to grant access to our library.
OralChemoEdSheets.com, the Patient and Healthcare Providers Resource
Tretinoin
(TREH-tih-NOYN)
(TREH-tih-NOYN)
Tretinoin (Vesanoid®) is used to treat adult and pediatric patients with acute promyelocytic leukemia (APL).
Tretinoin (Vesanoid®) is used to treat adult and pediatric patients with acute promyelocytic leukemia (APL).
Page 1 TER TRETINOIN ORAL CHEMOTHERAPY EDUCATION Name of your medication Generic name — tretinoin TREH tih NOYN Brand name — Vesanoid® VEH suh noyd Other name — ATRA all trans retinoic acid Approved uses Tretinoin is used to treat adult and pediatric patients with acute promyelocytic leukemia APL . Dose and schedule Taking tretinoin as instructed is important to allow your treatment to be as effective as possible, so here are some key points to remember. Your dose is based on many factors, including your height and weight, overall health, and diagnosis. Tretinoin should be taken with food, at the same time twice a day. Tretinoin should be taken whole and not crushed, cut, or dissolved. If you are unable to swallow tretinoin, talk to your care provider or pharmacist for possible options. If you miss a dose of tretinoin, do not take an extra dose or two doses at one time. Simply take your next dose at the regularly scheduled time. Be sure to write down if you miss a dose and let your care provider know about any missed doses. Storage and handling Handle tretinoin with care. Just like when chemotherapy is given into the vein, this drug can be toxic, and exposure of the drug to others should be limited. Store tretinoin at room temperature 68°F–77°F in a dry location away from light. Keep tretinoin out of reach of children and pets. Leave tretinoin in the provided packaging until it is ready to be taken. Whenever possible, give tretinoin to yourself and follow the steps below. If a family member, friend, or caregiver needs to give tretinoin to you, they also need to follow these steps: 1. Wash hands with soap and water. 2. Put on gloves to avoid touching the medication. Gloves are not necessary if you give the drug to yourself. 3. Gently transfer the tretinoin from its package to a small medicine or other disposable cup. 4. Administer the medicine immediately by mouth with water. 5. Remove gloves and do not use them for anything else. 6. Throw gloves and medicine cup in household trash. 7. Wash hands with soap and water. If a daily pill box or pill reminder is used, a separate one should be used for tretinoin. Do not mix other medications into the box with tretinoin. The person filling the box or reminder should wear gloves. Gloves are not necessary if you are filling the box or reminder. When empty, the box or reminder should be washed with soap and water before refilling. Be sure to wash hands with soap and water after the task is complete, whether or not gloves are worn.
Tucatinib (Tukysa™) is used to treat advanced or metastatic breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2). It is used in combination with trastuzumab and capecitabine.
Tucatinib (Tukysa™) is used to treat advanced or metastatic breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2). It is used in combination with trastuzumab and capecitabine.
Tukysa™ (Tucatinib) is used to treat advanced or metastatic breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2). It is used in combination with trastuzumab and capecitabine.
Tukysa™ (Tucatinib) is used to treat advanced or metastatic breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2). It is used in combination with trastuzumab and capecitabine.
Tykerb® (Lapatinib) is used in combination to treat advanced or metastatic breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2) receptor. It is used in combination with capecitabine or letrozole.
Tykerb® (Lapatinib) is used in combination to treat advanced or metastatic breast cancer that overexpresses human epidermal growth factor receptor 2 (HER2) receptor. It is used in combination with capecitabi...
Venclexta™ (Venetoclax) is used to treat chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also used in select patients with newly-diagnosed acute myeloid leukemia, in combination with azacitadine, decitabine, or low-dose cytarabine.
Venclexta™ (Venetoclax) is used to treat chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also used in select patients with newly-diagnosed acute myeloid leukemia, in combination with azacitadin...
Venetoclax (Venclexta™) is used to treat chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also used in select patients with newly-diagnosed acute myeloid leukemia, in combination with azacitadine, decitabine, or low-dose cytarabine.
Venetoclax (Venclexta™) is used to treat chronic lymphocytic leukemia or small lymphocytic lymphoma. It is also used in select patients with newly-diagnosed acute myeloid leukemia, in combination with azacitadin...
Verzenio™ (Abemaciclib) is used to treat adult patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanced or metastatic breast cancer.
Verzenio™ (Abemaciclib) is used to treat adult patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative advanced or metastatic breast cancer.